Risk of hepatocellular carcinoma among patients with hepatitis C virus cirrhosis treated with direct-acting antiviral therapy: An Australian experience

被引：0
|
作者：
Snell, J. [1 ,2 ]
Hong, T. [1 ]
Glasgow, S. [1 ]
Papaluca, T. [1 ]
New, K. [1 ]
Mcclure, T. [1 ]
Bell, S. [1 ]
Demeduik, B. [1 ]
Jeremiah, C. [1 ]
Tran, S. [1 ,2 ]
Phan, D. [1 ,2 ]
Jarman, M. [1 ,2 ]
Iser, D. [1 ]
Lust, M. [1 ]
Shaw, G. [1 ]
Desmond, P. [1 ]
Croagh, C. [1 ]
Visvanathan, K. [1 ]
Howell, J. [1 ]
Ryan, M. [1 ,2 ]
Thompson, A. J. [1 ,2 ]
机构：
[1] St Vincents Hosp, Dept Gastroenterol, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：80 / 81
页数：2
相关论文
共 50 条
  • [1] The Impact of Direct-acting Antiviral Therapy for Hepatitis C on Hepatocellular Carcinoma Risk
    Feng Su
    George N. Ioannou
    Current Hepatology Reports, 2018, 17 (4) : 377 - 384
  • [2] Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
    Lee, Chang Hun
    Kim, In Hee
    GUT AND LIVER, 2021, 15 (03) : 327 - 328
  • [3] Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma
    Lee, Shou-Wu
    Chen, Li-Shu
    Yang, Sheng-Shun
    Huang, Yi-Hsiang
    Lee, Teng-Yu
    VIRUSES-BASEL, 2022, 14 (11):
  • [4] The dynamic effect of direct-acting antiviral treatments on the risk of hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis C
    Lusivika-Nzinga, Clovis
    Fontaine, Helene
    Dorival, Celine
    Simony, Melanie
    Pol, Stanislas
    Carrat, Fabrice
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (12) : 1489 - 1492
  • [5] Patients with HIV and cirrhosis: the risk for hepatocellular carcinoma after direct-acting antivirals for hepatitis C virus
    Guardigni, Viola
    Toschi, Alice
    Badia, Lorenzo
    Del Turco, Elena Rosselli
    Salsi, Eleonora
    Cristini, Francesco
    Sighinolfi, Laura
    Fabbri, Gabriele
    Massari, Marco
    Cuomo, Gianluca
    Viale, Pierluigi
    Verucchi, Gabriella
    AIDS, 2021, 35 (12) : 1967 - 1972
  • [6] Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
    Tse, Chung Sang
    Yang, Ju Dong
    Mousa, Omar Y.
    Nelson, Kevin M.
    Pungpapong, Surakit
    Keaveny, Andrew
    Aqel, Bashar A.
    Vargas, Hugo
    Dickson, Rolland C.
    Watt, Kymberly
    Gores, Gregory J.
    Roberts, Lewis R.
    Leise, Michael D.
    TRANSPLANTATION DIRECT, 2021, 7 (01): : E635
  • [7] Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?
    Maan, Raoel
    Feld, Jordan J.
    GASTROENTEROLOGY, 2017, 153 (04) : 890 - 892
  • [8] RISK OF HEPATOCELLULAR CARCINOMA IN HCV-RELATED CIRRHOSIS TREATED WITH DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
    Kilany, Shimaa
    Gomaa, Asmaa Ibrahim
    Sabry, Alyaa
    Moaz, Inas
    Ezzat, Sameera
    Badra, Gamal Ahmed
    Waked, Imam
    HEPATOLOGY, 2019, 70 : 321A - 322A
  • [9] Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus plus Patients Treated with Direct-Acting Antiviral Agents
    Zou, Winnie Y.
    Choi, Kati
    Kramer, Jennifer R.
    Yu, Xian
    Cao, Yumei
    El-Serag, Hashem B.
    Kanwal, Fasiha
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (11) : 3328 - 3336
  • [10] Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents
    Winnie Y. Zou
    Kati Choi
    Jennifer R. Kramer
    Xian Yu
    Yumei Cao
    Hashem B. El-Serag
    Fasiha Kanwal
    Digestive Diseases and Sciences, 2019, 64 : 3328 - 3336
12345